CTOs on the Move

Desktop Health

www.desktophealth.com

 
Desktop Health is a leading global provider of professional-grade 3D printing solutions. Our company invents, develops, manufactures and sells 3D printers and proprietary materials worldwide.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Advogent

Advogent is a Wayne, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Care Inc

Community Care Inc is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nutrition Management Services Company

Nutrition Management Services Company is a Kimberton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Peninsula Community Mental Health Center

Peninsula Community Mental Health Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Peninsula Community Mental Health Center is based in Port Angeles, WA. You can find more information on Peninsula Community Mental Health Center at www.pcmhc.org

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.